ProSciento

ProSciento is a specialized contract research organization (CRO) built around clinical development in metabolic diseases across the continuum—from diabetes and obesity to MASLD/MASH, cardiovascular disease, and chronic kidney disease.

Expertise & Differentiation

• Metabolic Disease Focus: Over two decades of dedicated experience in interconnected metabolic conditions, recognizing shared risk factors and overlapping biology.
• Integrated Partnership Model: Engages as a fully integrated partner from early scientific strategy through Phase 3, not a transactional vendor.
• Proprietary Participant Registry: Nationwide registry of 180,000+ participants, each with 200+ metabolic characterization data points, built through genuine relationships with sites and participants over 20+ years.
• Full-Service Capabilities: Supports every stage of clinical development from first-in-human studies through Phase 3 and beyond, with intentional design to leverage scientific expertise and drive operational excellence.
• Scientific Depth: Team brings clinical expertise and genuine scientific understanding of metabolic complexity, enabling more accurate feasibility assessments, stronger recruitment, and better retention.

Mission & Values

Driven by the mission to find better treatments for diseases across the metabolic continuum. Core values include continuous improvement, ownership, collaborative partnership, living values even when challenging, and building sustainable community.